LRMR - Larimar Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LRMR is currently covered by 6 analysts with an average price target of $12.63. This is a potential upside of $9.96 (373.03%) from yesterday's end of day stock price of $2.67.

Larimar Therapeutics's activity chart (see below) currently has 88 price targets and 100 ratings on display. The stock rating distribution of LRMR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.74% with an average time for these price targets to be met of 141.14 days.

Highest price target for LRMR is $18, Lowest price target is $5, average price target is $12.63.

Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 14-Sep-2026. First documented stock forecast 20-Mar-2015.

Best performing analysts who are covering LRMR - Larimar Therapeutics:

Jason Butler Edward Tenthoff Yatin Suneja Samantha Semenkow

Currently out of the existing stock ratings of LRMR, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Mar-2015

$13

$10.33 (386.89%)

$132

26 days ago
(14-Sep-2026)

1/5 (20%)

$9.22 (243.92%)

1022

Buy Since 03-Oct-2024

$11

$8.33 (311.99%)

$12

2 months 5 days ago
(05-Aug-2026)

0/9 (0%)

$6.9 (168.29%)

Buy Since 10-Feb-2021

$18

$15.33 (574.16%)

$18

3 months 3 days ago
(07-Jul-2026)

0/15 (0%)

$14.59 (427.86%)

Buy Since 03-Sep-2024

$5

$2.33 (87.27%)

$7

3 months 10 days ago
(30-Jun-2026)

0/5 (0%)

$1.95 (63.93%)

Buy Since 13-Feb-2024

$14

$10.34 (282.51%)

$12

7 months 15 days ago
(25-Feb-2026)

3/8 (37.5%)

$8.05 (135.29%)

88

Show more analysts

Please expand the browser size to see the chart

What is LRMR (Larimar Therapeutics) average time for price targets to be met?

On average it took 141 days for the stock forecasts to be reached, with an average price target met ratio of 16.74%.

Which analyst most recently updated their price target on LRMR (Larimar Therapeutics)?

Joseph Schwartz

Which analyst has the most public recommendations on LRMR (Larimar Therapeutics)?

Joseph Schwartz works at LEERINK and has 3 price targets and 3 ratings on LRMR

Which analyst is the currently most bullish on LRMR (Larimar Therapeutics)?

Edward Nash with the highest potential upside of $81.33

Which analyst is the currently most reserved on LRMR (Larimar Therapeutics)?

Jason Butler with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?